Title of Invention

A PHARMACEUTICAL COMPOSITION COMPRISING TEGASEROD AND A PROCESS FOR ITS PRODUCTION

Abstract The present invention relates to a solid pharmaceutical composition for oral adminstration comprising tegaserod in base or salt form in an amount of up to 10% by weight, a diluent in an amount of 70 to 90% by weight, a disintegrant in an amount of less than 15% by weight, and wherein the amounts by weight are based on the total weight of the composition. The present invention also relates to a process for the production of a solid pharmaceutical composition as claimed in any preceding claim which process is carried out under substantially dry conditions using granulation.
Full Text

Documents:

0970-mas-2002 abstract-duplicate.pdf

0970-mas-2002 abstract.pdf

0970-mas-2002 claims-duplicate.pdf

0970-mas-2002 claims.pdf

0970-mas-2002 correspondences others.pdf

0970-mas-2002 correspondences po.pdf

0970-mas-2002 description (complete)-duplicate.pdf

0970-mas-2002 description (complete).pdf

0970-mas-2002 form-1.pdf

0970-mas-2002 form-18.pdf

0970-mas-2002 form-26.pdf

0970-mas-2002 form-3.pdf

0970-mas-2002 form-5.pdf

0970-mas-2002 pct search report.pdf

0970-mas-2002 pct.pdf

0970-mas-2002 petition.pdf


Patent Number 228907
Indian Patent Application Number 970/MAS/2002
PG Journal Number 12/2009
Publication Date 20-Mar-2009
Grant Date 11-Feb-2009
Date of Filing 20-Dec-2002
Name of Patentee NOVARTIS AG
Applicant Address LICHTSTRASSE 35, CH-4056 BASEL,
Inventors:
# Inventor's Name Inventor's Address
1 AUBERT JEROME 4 RUE DE LA FECULERIE, 45150 JARGEAU,
2 VITZLING CHRISTIAN 39 RUE DE POMMARD, 75012 PARIS,
PCT International Classification Number A61K 9/00
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 01403339.3 2001-12-21 EUROPEAN UNION